Caren van Roekel

280 Chapter 10 12. Shibata T, Niinobu T, Ogata N, Takami M. Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer. 2000;89(2):276-84. 13. Ruers T, Van Coevorden F, Punt CJ, Pierie JE, Borel-Rinkes I, Ledermann JA, et al. Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial. J Natl Cancer Inst. 2017;109(9). Epub 2017/04/05. 14. Puijk RS, Ruarus AH, Vroomen L, van Tilborg A, Scheffer HJ, Nielsen K, et al. Colorectal liver metastases: surgery versus thermal ablation (COLLISION) - a phase III single-blind prospective randomized controlled trial. BMC Cancer. 2018;18(1):821. Epub 2018/08/17. 15. Renouf DJ, Lim HJ, Speers C, Villa D, Gill S, Blanke CD, et al. Survival for metastatic colorectal cancer in the bevacizumab era: a population-based analysis. Clin Colorect Cancer. 2011;10(2):97-101. Epub 2011/08/24. 16. Heinemann V, von Weikersthal LF, Decker T, Kiani A, Vehling-Kaiser U, Al- Batran S-E, et al. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial. Lancet Oncol. 2014;15(10):1065-75. 17. Jawed I, Wilkerson J, Prasad V, Duffy AG, Fojo T. Colorectal Cancer Survival Gains and Novel Treatment Regimens: A Systematic Review and Analysis. JAMA Oncology. 2015;1(6):787-95. Epub 2015/07/17. 18. J.W. C, Grothey A . Sys temic chemotherapy for nonoperable metastatic colorectal cancer: Treatment recommendations. 2020 [cited 2020 March 9]; Available from: https://www. uptodate.com/content s/s ys temic- chemot her apy - fo r- nonoper ab l e - m e t a s t a t i c- c o l o r e c t a l - c a n c e r- treatment-recommendations?search= colorectal%20cancer%20systemic%20 t r e a t m e n t & s o u r c e = s e a r c h _ result&selectedTitle=1~150&usage_ type=default&display_rank=1. 19. Lamont EB, Schilsk y RL. The oral fluoropyrimidines in cancer chemotherapy. Clinl Cancer Res. 1999;5:2289-96. 20. Fujita K, Kubota Y, Ishida H, Sasaki Y. Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer. World J Gastroenterol. 2015;21(43):12234-48. Epub 2015/11/26. 21. Koopman M, Antonini NF, Douma J, Wals J, Honkoop AH, Erdkamp FLG, et al. Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial. Lancet. 2007;370(9582):135-42. 22. Seymour MT, Maughan TS, Ledermann JA, Topham C, James R, Gwyther SJ, et al. Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial. Lancet. 2007;370(9582):143-52.